lunes, 9 de diciembre de 2019

Aducanumab: the beginning of the end of Alzheimer's disease? - STAT

Aducanumab: the beginning of the end of Alzheimer's disease? - STAT

First Opinion

Aducanumab: the beginning of the end of Alzheimer’s disease?

By JASON KARLAWISH


HULTON ARCHIVE/GETTY IMAGES
If approved, aducanumab won't end Alzheimer's because it cures the disease. It doesn't do that. But it will treat our Alzheimer's culture.

No hay comentarios: